Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heejung Chae

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Experimental & Molecular Medicine|April 16, 2026
Delineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypesSunmin Kim, Seeyoun Lee, Hyeji Kim, et al.
Scientific Reports|October 16, 2024
Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variantYoon-Jung Choi, Younju Park, Boyoung Park, et al.
Journal of Breast Cancer|April 10, 2018
<i>FcrR3A</i>-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based TreatmentHeejung Chae, Changhoon Yoo, Jung-A Yoon, et al.
Cancer Research and Treatment|July 8, 2021
Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 ExpressionHeejung Chae, Jeong Eun Kim, Wanlim Kim, et al.
Leukemia & Lymphoma|January 7, 2020
Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOPJunho Kang, Heejung Chae, Jung Yong Hong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 8, 2025
Outcomes and effectiveness of decision aids for families affected by hereditary cancer syndromes: A scoping reviewSun Young Park, Youlim Kim, Maria C Katapodi, et al.
Cancers|June 19, 2024
Healthcare Professionals' Learning Needs and Perspectives on Essential Information in Genetic Cancer Care: A Systematic ReviewSun-Young Park, Youlim Kim, Maria C Katapodi, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
Experimental & Molecular Medicine|November 1, 2024
Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevanceKyong-Ah Yoon, Youngwook Kim, So-Youn Jung, et al.
Cancers|September 28, 2024
Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI)Heejung Chae, Sung Hoon Sim, Youngmi Kwon, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Experimental & Molecular Medicine|April 16, 2026
Delineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypesSunmin Kim, Seeyoun Lee, Hyeji Kim, et al.
Scientific Reports|October 16, 2024
Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variantYoon-Jung Choi, Younju Park, Boyoung Park, et al.
Journal of Breast Cancer|April 10, 2018
<i>FcrR3A</i>-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based TreatmentHeejung Chae, Changhoon Yoo, Jung-A Yoon, et al.
Cancer Research and Treatment|July 8, 2021
Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 ExpressionHeejung Chae, Jeong Eun Kim, Wanlim Kim, et al.
Leukemia & Lymphoma|January 7, 2020
Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOPJunho Kang, Heejung Chae, Jung Yong Hong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 8, 2025
Outcomes and effectiveness of decision aids for families affected by hereditary cancer syndromes: A scoping reviewSun Young Park, Youlim Kim, Maria C Katapodi, et al.
Cancers|June 19, 2024
Healthcare Professionals' Learning Needs and Perspectives on Essential Information in Genetic Cancer Care: A Systematic ReviewSun-Young Park, Youlim Kim, Maria C Katapodi, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
Experimental & Molecular Medicine|November 1, 2024
Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevanceKyong-Ah Yoon, Youngwook Kim, So-Youn Jung, et al.
Cancers|September 28, 2024
Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI)Heejung Chae, Sung Hoon Sim, Youngmi Kwon, et al.
Pageof 5